Zum Inhalt springen
Psoriasis-News
  • Long-term persistence of second-line biologics in psoriatic arthritis patients with prior TNF inhibitor exposure: a nationwide cohort study from the French health insurance database (SNDS) - PubMed

     Teilen


    Full text linksCite Display options Display options Introduction: Tumour necrosis factor inhibitor (TNFi) agents are most often the first-choice …

    Den ganzen Artikel lesen


    Automat
     Teilen



×
×
  • Neu erstellen...